A multiplexed fiber optic microsphere-based immunoassay array capable of simultaneously measuring five
inflammatory cytokines has been developed. Five groups of amine-functionalized 3.1 micron microspheres were
internally encoded with five distinct concentrations of a europium dye and converted to cytokine probes by covalently
coupling monoclonal capture antibodies specific for human VEGF, IFN-gamma, RANTES, IP-10, and Eotaxin-3 to the
microspheres via glutaraldehyde chemistry. The microspheres were pooled and loaded into a 1 mm diameter fiber optic
bundle containing ~50,000 individual etched microwells, producing the multiplexed cytokine immunoassay array.
Multiple arrays can be created from a single microsphere pool for high throughput sample analysis. Sandwich
fluoroimmunoassays were performed by incubating the probe array in a sample, followed by incubation in a mixture of
biotin-labeled detection antibodies that are complementary to the five cytokines. Finally, universal detection of each
protein was performed using a fluorescence imaging system after briefly immersing the array in a solution of
fluorophore-labeled streptavidin. The multiplexed cytokine array has been shown to respond selectively to VEGF, IFNgamma,
RANTES, IP-10, and Eotaxin-3, permitting multiplexed quantitative analysis. Ultimately, the multiplexed
cytokine array will be utilized to evaluate the potential of using saliva as a noninvasive diagnostic fluid for pulmonary
inflammatory diseases such as asthma.
Saliva presents a minimally invasive alternative medium to blood for performing diagnostics1. Microsphere sensors for ions, small organic molecules, and proteins are currently being developed and optical microarrays containing thousands of these sensors will be used for simultaneous multi-analyte analysis. The fiber bundle platform in use is 1mm in diameter and contains approximately 50,000 individually addressable 3.1μm fibers, each with an etched well capable of housing a single 3.1μm microsphere sensor. Micron-sized bead-based chemistries are produced in house, followed by deposition onto a fiber-optic bundle platform, allowing for multiplexed analysis. The ultimate goal is to develop a universal diagnostic system using saliva as the diagnostic medium. This platform will permit multiplexed analysis of a sample by integrating microfluidics with the optical arrays loaded with sensors capable of detecting relevant biomarkers associated with a wide range of disease states.
Disease states that are currently under investigation include end stage renal disease (ESRD) and Sjoegrens Syndrome (SS).
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.